Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
17.06. | When Innovation Outpaces Adoption, Patients Pay the Price | ||
17.06. | The AI Advantage: Navigating the 2026 Medicare Advantage Rate Bump | ||
17.06. | How Wearables Are Changing the Way We Monitor Cancer Treatment | ||
17.06. | Rising Healthcare Costs: What Employers Are Doing to Manage Expenses, Per Mercer | ||
17.06. | How Badly Would Medicaid Cuts Hurt Healthcare Access in Rural America? | ||
16.06. | Sarepta Stops Stop Shipments of Muscular Dystrophy Gene Therapy After Second Patient Death | ||
16.06. | The ER Is Bursting at the Seams - Employers Hold the Key to Change | ||
16.06. | 6 Questions To Ask Before Integrating AI Into A Clinical Workflow | ||
16.06. | INVEST Pitch Perfect Spotlight: How DUOS Is Leveraging Tech To Support Older Adults | ||
15.06. | ASCO 2025 Recap: Rise of the Bispecifics, Dueling Degraders, ADCs of Interest & More | ||
15.06. | Attacking Food Allergies: How Technology can Ease the Path to New Treatments Without the Pain | ||
15.06. | If We Treated Tooth Decay Like We Treat Heart Disease, We'd Save Billions | ||
13.06. | Blue Shield of California, Zocdoc Partner To Help Members Schedule Care | ||
13.06. | AstraZeneca Turns to CSPC Pharma Again, Putting Up $110M to Start Multi-Drug R&D Pact | ||
13.06. | Maximizing Equipment Uptime with Predictive Maintenance Technologies | ||
13.06. | How AI Is Helping Psychiatrists Make Faster, Smarter Treatment Decisions | ||
13.06. | The Essential Guide to Practice Management Software for Therapists | ||
12.06. | Omada & Hinge's IPO Debuts Signal Success for Digital Health Market, Experts Say | ||
12.06. | BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute | ||
12.06. | The Employer's Dilemma: When the Fully Insured Plan No Longer Works, What's Next for Employers? | ||
12.06. | How to Meet the Digital Needs of Each Generation of Patients | ||
12.06. | Capital Rx Expands Into Care Navigation with Acquisition of Amino Health | ||
11.06. | Bristol Myers Squibb Is Paying $350M to Expand Its Reach in Radiopharmaceuticals to Prostate Cancer | ||
11.06. | 'We Dissent': NIH Workers Protest Trump Policies That 'Harm the Health of Americans' | ||
11.06. | Managing Routine Radiology: An Opportunity to Control Costs and Improve Care |